These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 22822092

  • 1. Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.
    Marckmann P, Agerskov H, Thineshkumar S, Bladbjerg EM, Sidelmann JJ, Jespersen J, Nybo M, Rasmussen LM, Hansen D, Scholze A.
    Nephrol Dial Transplant; 2012 Sep; 27(9):3523-31. PubMed ID: 22822092
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
    Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, Holland-Letz T, Weiner SM, Rump LC.
    Nephrol Dial Transplant; 2008 Dec; 23(12):4016-20. PubMed ID: 18593741
    [Abstract] [Full Text] [Related]

  • 5. Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial.
    Massart A, Debelle FD, Racapé J, Gervy C, Husson C, Dhaene M, Wissing KM, Nortier JL.
    Am J Kidney Dis; 2014 Nov; 64(5):696-705. PubMed ID: 24856872
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study.
    Delanaye P, Weekers L, Warling X, Moonen M, Smelten N, Médart L, Krzesinski JM, Cavalier E.
    Nephrol Dial Transplant; 2013 Jul; 28(7):1779-86. PubMed ID: 23378417
    [Abstract] [Full Text] [Related]

  • 10. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F, Carvalho AB, Pillar R, Rocha LA, Cassiolato JL, Cuppari L, Canziani MEF.
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [Abstract] [Full Text] [Related]

  • 11. Predictors of vitamin D status in predialysis chronic kidney disease patients: a cross-sectional analysis in a high ultraviolet climate.
    Petchey WG, Johnson DW, Hawley CM, Isbel NM.
    J Ren Nutr; 2012 Jul; 22(4):400-8. PubMed ID: 22074789
    [Abstract] [Full Text] [Related]

  • 12. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
    Alvarez JA, Law J, Coakley KE, Zughaier SM, Hao L, Shahid Salles K, Wasse H, Gutiérrez OM, Ziegler TR, Tangpricha V.
    Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone as a mortality predictor in frail aged inpatients.
    Bjorkman M, Sorva A, Tilvis R.
    Gerontology; 2009 Sep; 55(6):601-6. PubMed ID: 19752529
    [Abstract] [Full Text] [Related]

  • 14. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.
    Ramirez-Sandoval JC, Arvizu-Hernandez M, Cruz C, Vazquez-Cantu B, Rojas-Concha LJ, Tamez L, Reynerio F, Gomez FE, Correa-Rotter R.
    J Nephrol; 2019 Aug; 32(4):645-659. PubMed ID: 30888584
    [Abstract] [Full Text] [Related]

  • 15. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [Abstract] [Full Text] [Related]

  • 16. Vascular function and cholecalciferol supplementation in CKD: A self-controlled case series.
    Kumar V, Yadav AK, Singhal M, Kumar V, Lal A, Banerjee D, Gupta KL, Jha V.
    J Steroid Biochem Mol Biol; 2018 Jun; 180():19-22. PubMed ID: 29309832
    [Abstract] [Full Text] [Related]

  • 17. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
    Bucharles S, Barberato SH, Stinghen AEM, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R.
    J Ren Nutr; 2012 Mar; 22(2):284-291. PubMed ID: 21908203
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral cholecalciferol versus ultraviolet radiation B: effect on vitamin D metabolites in patients with chronic pancreatitis and fat malabsorption - a randomized clinical trial.
    Bang UC, Matzen P, Benfield T, Beck Jensen JE.
    Pancreatology; 2011 Mar; 11(4):376-82. PubMed ID: 21894054
    [Abstract] [Full Text] [Related]

  • 20. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL, Hristova M, Ho LT, Sprague SM.
    Am J Nephrol; 2007 Mar; 27(1):36-43. PubMed ID: 17215573
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.